Mark Lubkeman - Senior Partner and Managing Director at the Boston Consulting Group.

Mark has 31 years’ consulting experience in the health care industry.  Until recently he led the Boston Consulting Group's Global Biopharma business as well as BCG's Heath Care Practice in North America.  

Mark is a strategy expert and has wide ranging experience helping biopharma and medical device companies, analyzing/defining optimal corporate/BU strategy and commercial arrangements as well as several strategy development projects, generally focused on accelerating growth in key markets. Mark regularly works with private equity companies and portfolio companies, ranging from strategic due diligence to full potential plans/transformations, to focused strategy and operational performance improvements . Furthermore, Mark is supporting a range of Boston Consulting CEO coaching/succession efforts for Boards and CEOs, ranging across transition design/planning, selection, expertise development, and onboarding.

Mark spent much of his career on the US West Coast, some time in Zurich and now in London. He has deep experience in helping companies in North America, Europe/MEA and Asia achieve competitive advantage by enhanced winning corporate strategies, capabilities, and organisations. Mark has also worked with a range of earlier-stage companies and chairs the Advisory Board for IntraBio.

Mark has a BA in Economics from Harvard University and an MBA from the Harvard Graduate School of Business